BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - IND
Stemline Therapeutics, Inc. (STML) Announces FDA Acceptance Of IND For SL-701, A Synthetic Multi-Peptide Vaccine Targeting Glioma Brain Tumors 4/8/2014  More...
FDA Lifts Clinical Hold On Oxygen Biotherapeutics, Inc. (OXBT)'s Program 3/31/2014  More...
Geron Corporation (GERN) Says FDA Halts Patient Enrollment In Another Cancer Trial 3/21/2014  More...
Summit Corporation Announces FDA Clearance Of IND Application For Phase 2 Study Of SMT19969 To Treat C. Difficile Infection 3/18/2014  More...
IntelliCell BioSciences (SVFC) Announces It Will File An IND For Osteoarthritis Of The Knee In Conjunction With The Andrews's Research And Educational Foundation 3/17/2014  More...
PharmaRoth Labs, Inc. Announces Results From FDA Application 3/17/2014  More...
Geron Corporation (GERN) Tanks As FDA Halts Development Of Blood Disorder Drug 3/13/2014  More...
Celsus Therapeutics (CLTX) Provides Update On MRX-6 From FDA Pre-IND Meeting 3/12/2014  More...
Alcobra (ADHD) Announces FDA Clearance Of IND For Metadoxine Extended Release (MDX) 3/6/2014  More...
Omeros Corporation (OMER) Submits IND To Advance OMS721 Phase 2 Clinical Program 3/4/2014  More...
TONIX Pharmaceuticals, Inc. Completes Pre-IND Meeting With FDA On TNX-201 For Episodic Tension-Type Headache: Clinical Development To Begin In 4Q 2014 3/3/2014  More...
Ignyta Announces Submission Of IND For RXDX-101 2/27/2014  More...
rEVO Biologics Announces The Submission Of An IND For Atryn® In Preeclampsia 2/25/2014  More...
International Stem Cell Corporation Completes Pre-IND Meeting With FDA For Parkinson's Disease Cell Therapy 2/18/2014  More...
Regado Biosciences, Inc. (RGDO), Announces FDA Acceptance Of IND For REG2 2/13/2014  More...
BioMarin Pharmaceutical Inc. (BMRN) Announces Selection Of NAGLU Fusion Protein Drug Development Candidate BMN 250 For The Treatment Of Sanfilippo B (MPS IIIB) 2/11/2014  More...
Galectin Therapeutics Supports Investigational New Drug (IND) Application For Its Galectin Inhibitor GR-MD-02 In Metastatic Melanoma 1/15/2014  More...
Benitec, Inc. (BLT.AX) Release: Hepatitis C Trial To Proceed 1/14/2014  More...
Wilson Therapeutics Announces Successful Filing Of U.S. IND To Advance WTX101 Development Program For Wilson Disease 1/14/2014  More...
Kala Pharmaceuticals Announces IND Submission Of Its MPP-Formulated Loteprednol Etonbonate (LE-MPP) For Post-Cataract Surgery 1/6/2014  More...
Harvard Apparatus Regenerative Technology Files Pre-IND Meeting Documents And Orphan Biologics Application With U.S. FDA 1/6/2014  More...
Cellceutix (CTIX) Submits Application To Institutional Review Board to Commence Clinical Trials Of Anti-Psoriasis Drug Prurisol 1/6/2014  More...
FDA Lifts Hold On Studies Testing Cell Therapeutics, Inc. (CTIC)'s Cancer Drug Tosedostat 1/2/2014  More...
Shield Therapeutics Release: FDA Grants Approval Of IND To Commence A Phase 3 Pivotal Study For ST10 For The Treatment Of Iron Deficiency Anemia In Chronic Kidney Disease 12/16/2013  More...
Interim Results From Gentium S.p.A.'s Treatment IND For Defibrotide And Additional Data On Defibrotide In The Prevention Of Acute Graft Versus Host Disease (Agvhd) Presented At The American Society of Hematology Annual Meeting 12/11/2013  More...
Raptor Pharmaceutical Inc. (RPTP) Submits IND For RP103 For Leigh Syndrome And Other Mitochondrial Disorders 12/10/2013  More...
Coronado Biosciences (CNDO) Announces IND Submission For TSO For The Treatment Of Moderate To Severe Chronic Plaque Psoriasis 12/9/2013  More...
ARCA biopharma Announces FDA Acceptance Of Gencaro IND Application For The Treatment Of Atrial Fibrillation 12/4/2013  More...
Chikujee Initiates IND-Enabling Study For Programmable Therapeutic-CT-187MDR For The Treatment Of Multidrug Resistant Ovarian Cancer 11/15/2013  More...
Discovery Laboratories (DSCO) Receives FDA Clearance Of IND To Initiate AEROSURF® Phase 2 Clinical Program 11/13/2013  More...
Innate Pharma (IPH.PA ): Launch of IND-Enabling Studies for IPH4102 11/8/2013  More...
Star Scientific , Inc. Announces Leadership Transition, Acceleration of Plans for Submission of an IND to FDA for Pharmaceutical Version of Anatabine Compound 11/8/2013  More...
Aclaris Therapeutics Initiates IND-Directed Program for A-101 for the Treatment of Seborrheic Keratosis, Common Type of Skin Tumor 11/6/2013  More...
Repros Therapeutics Inc. (RPRX) Receives FDA Guidance for Proellex® Low Dose Oral Uterine Fibroid Clinical Program 11/5/2013  More...
ARCA biopharma Announces IND Submission to FDA for Gencaro for the Treatment of Atrial Fibrillation 10/29/2013  More...
Polaris Group Files New IND for ADI-PEG 20 in Breast Cancer 10/22/2013  More...
RedHill Biopharma Ltd. (RDHL) Announces FDA Acceptance of IND Application for RHB-105 (H. pylori) Phase 3 Study - to Commence Shortly 10/22/2013  More...
Discovery Laboratories (DSCO) Announces IND Submission for AEROSURF® 10/18/2013  More...
Flatley Discovery Lab, LLC Nominates Clinical Candidate for Treatment of Cystic Fibrosis 10/11/2013  More...
CFDA Accepts Sihuan Pharmaceutical Holdings Group Ltd. 's Application for Clinical Trial Approval for Self-Developed Innovative Oncology Drug Pirotinib 10/10/2013  More...
StemCells Inc. (STEM) Receives FDA Authorization of IND for Spinal Cord Injury 10/2/2013  More...
Advanced Cell Technology Files Investigational New Animal Drug (INAD) Application With FDA to Treat 10 Different Disease Indications Using Pluripotent Stem Cells 9/19/2013  More...
GenKyoTex S.A. Receives FDA IND Approval for Phase II Clinical Study With First in Class NOX Inhibitor GKT137831 9/9/2013  More...
International Stem Cell Corporation Advances Parkinson's Disease Program Towards IND Stage 9/9/2013  More...
Oramed Pharmaceuticals Inc. (ORMP.OB) Submits Pre-IND Package to FDA for ORMD-0901 (oral exenatide), an Oral GLP-1 Analog for the Treatment of Type 2 Diabetes 9/3/2013  More...
Transdermal Delivery Solutions Subsidiary, Hormone Replacement Technologies, Receives FDA Approval to Begin Pivotal Clinical Trials of Testagen® TDS for the Treatment of Low Testosterone 8/22/2013  More...
To-BBB technologies BV Receives IND Approval for Novel Brain Cancer Drug, 2B3-101 8/19/2013  More...
Altor BioScience Corporation Launches Its Proprietary IL-15 Superagonist ALT-803 Into Clinical Trials Against Cancer 8/15/2013  More...
GW Pharmaceuticals Opens an Investigational New Drug Application (IND) in the United States for a Sativex® Phase 3 Clinical Program as a Treatment for Spasticity Due to Multiple Sclerosis 8/14/2013  More...
Atlantic Pharmaceuticals, Inc. Announces Successful Pre-IND Meeting With the FDA on Immediate Release, Abuse-Deterrent Hydrocodone 8/13/2013  More...
Jubilant BioSys Ltd. Announces Successful Filing of Investigational New Drug With US-based Endo Pharmaceuticals (ENDP) 8/7/2013  More...
ImmunoGen, Inc. (IMGN) Announces FDA Acceptance of IND for Company's Novel EGFR-Targeting ADC, IMGN289 8/2/2013  More...
Oramed Pharmaceuticals Inc. (ORMP.OB) Submits Pre-IND Meeting Request to FDA for Its Oral Exenatide Capsule ORMD-0901 7/30/2013  More...
PreScience Labs Announced that the FDA Accepts IND Application for Novel Oncology Drug 7/24/2013  More...
Charleston Laboratories, Inc. Announces Successful Completion of Pre-IND Meeting on New Migraine Treatment CL-H1T 7/23/2013  More...
Kinex Pharmaceuticals Announces that the US FDA Allows their IND for Oraxol, an Oral Form of Paclitaxel That is in Phase II Clinical Trials in Korea, to Begin Clinical Trials in the US 7/22/2013  More...
Genmab A/S (GEN.CO) Files IND for HuMax-TF-ADC 7/18/2013  More...
Rexahn Pharmaceuticals, Inc. Announce IND Submission for RX-3117 7/15/2013  More...
Pluristem Therapeutics (PSTI)'s South Korean Partner Files IND With Korean FDA for PLX Cells 7/8/2013  More...
Astex Pharmaceuticals (ASTX) Announces IND Candidate: ASTX727 a Potential Best-in-Class Oral Hypomethylator 7/8/2013  More...
Signum Dermalogix Investigational New Drug (IND) Application Cleared by FDA: SIG990 a Potential Treatment for Rosacea 7/8/2013  More...
La Jolla Pharmaceutical Company (LJPC) Announces FDA Acceptance of IND for LJPC-501 7/2/2013  More...
FDA Granted Fast Track Designation for Genervon's Breakthrough Biotechnology Multi-Target ALS Drug GM604 Expediting Drug Approval Process 6/27/2013  More...
TherapeuticsMD, Inc. Investigational New Drug Filing Accepted by FDA 6/13/2013  More...
FDA Accepts IND Application for Edge Therapeutics' EG-1962 (nimodipine microparticles) 6/10/2013  More...
Bio-Matrix Scientific Group Inc. (BMSN.OB)'s Regen BioPharma Submits Response to FDA Questions Regarding HemaXellerate Clinical Program 6/7/2013  More...
AVANIR Pharmaceuticals (AVNR) Announces Accelerated Development Path for AVP-786 Following Successful Pre-IND Meeting With FDA 6/5/2013  More...
La Jolla Pharmaceutical Company (LJPC) Submits IND for LJPC-501 6/4/2013  More...
Sunshine Biopharma, Inc. Announces That Its Breast Cancer Drug Candidate, Adva-27a, Also Destroys Pancreatic Cancer Cells 6/4/2013  More...
Biovista and the CFIDS Association of America Achieve Drug Repositioning Milestone With Pre-IND Meeting 5/29/2013  More...
Omeros Corporation (OMER) Release: Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 5/23/2013  More...
Perosphere Inc. Receives FDA IND Clearance to Initiate Clinical Investigations of the Safety and Efficacy of PER977 to Reverse the Activity of Anticoagulation Therapies Including Factor Xa- and IIa-Inhibitors 5/22/2013  More...
Oramed Pharmaceuticals Inc. (ORMP.OB) Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 5/17/2013  More...
Enanta Pharmaceuticals, Inc. Release: Breakthrough Therapy Designation From the FDA Granted to Investigational HCV Regimen Containing Protease Inhibitor ABT-450 5/6/2013  More...
RNL Bio Files IND to Commence Phase II Clinical Trial of RNL-JointStem for Osteoarthritis in the United States 5/2/2013  More...
R-Tech Ueno Receives FDA IND Approval for RU-101 (r-HSA) to Treat Severe Dry Eye 4/26/2013  More...
SK Bio-Pharmaceuticals Announces FDA's Authorization of IND for SKL15508 4/17/2013  More...
FDA Grants Charleston Laboratories, Inc. Request for Pre-IND Meeting on New Migraine Treatment 4/16/2013  More...
Oramed Pharmaceuticals Inc. (ORMP.OB) Submits New IND Application for Oral Insulin Trial in the US 4/11/2013  More...
Boston Therapeutics, Inc. Requests an IND Meeting With the FDA for PAZ320 to Reduce Postprandial Hyperglycemia in Type 2 Diabetes 4/11/2013  More...
Lipid Therapeutics Successfully Files a U.S. IND for LT-02, a Novel Barrier Function Therapy for Ulcerative Colitis 4/10/2013  More...
ERYtech Pharma Receives FDA IND Clearance to Initiate a Clinical Study in Acute Lymphoblastic Leukemia in the U.S. 4/3/2013  More...
Cleveland Biolabs Inc. (CBLI) and Incuron Announce Notice of Allowance From FDA to Commence Clinical Testing With CBL0137 4/2/2013  More...
Soligenix (SNGX.OB) Receives IND Clearance From FDA to Initiate Clinical Program to Evaluate SGX942 for the Treatment of Oral Mucositis 3/27/2013  More...
Regen BioPharma Receives IND From FDA for HemaXellerate 3/18/2013  More...
Immunotech Laboratories in Discussions for Pre-"IND" Testing of Aids-HIV "IPF" Treatment in the USA 3/18/2013  More...
Sunshine Biopharma, Inc. Commences Negotiations With Contract Manufacturing Organizations for Production of Its Multidrug-Resistant Breast Cancer Drug, Adva-27a 3/14/2013  More...
La Jolla Pharmaceutical Company (LJPC) Announces FDA Agreement With Proposed IND Submission for LJPC-501 in Hepatorenal Syndrome 3/4/2013  More...
Sunshine Biopharma, Inc. Reports on IND Research for Its Novel Breast Cancer Drug Candidate, Adva-27a 2/26/2013  More...
Ampio Pharmaceuticals, Inc. (AMPE) Modifies Ampion™ IND for Osteoarthritis of the Knee to Include a Dose Escalation Run-In Study and Prepares to Launch Pivotal Clinical Trial 2/25/2013  More...
Scioderm's Investigational New Drug (IND) Application for SD-101 for Treatment of Epidermolysis Bullosa (EB) Allowed by the FDA 2/14/2013  More...
FDA Agreement on Mesoblast Limited's Use of Singapore Manufacturing Facility for Clinical Trial Production of Proprietary Mesenchymal Precursor Cells 2/13/2013  More...
Regen BioPharma Files Investigational New Drug (IND) Application With FDA on HemaXellerate I™ Stem Cell Drug for Aplastic Anemia 2/5/2013  More...
Galectin Therapeutics Announces Submission of an Investigational New Drug (IND) Application for the Treatment of Fatty Liver Disease 1/31/2013  More...
ImmunoCellular Therapeutics, Ltd' Investigational New Drug (IND) Application for ICT-140 Allowed by the FDA 1/29/2013  More...
Regen BioPharma Peer-Reviewed Publication Provides Preclinical Support for HemaXellerate™ Bone Marrow Failure Product 1/25/2013  More...
PledPharma Release: FDA Has Approved IND Application for Clinical Trial With PledOx in the U.S. 1/22/2013  More...
Ampio Pharmaceuticals, Inc. (AMPE) Announces Active IND for Optina™ for the Treatment of Diabetic Macular Edema (DME) 1/22/2013  More...
Clearside Biomedical Announces Plans for Clinical Testing of CLS1001 (Triamcinolone Acetonide) Suprachoroidal Injectable Suspension for the Treatment of Some Eye Diseases 1/10/2013  More...
Soligenix (SNGX.OB) Receives IND Clearance From FDA to Initiate Program Evaluating OrbeShieldTM as a Therapy for Gastrointestinal Acute Radiation Syndrome 1/4/2013  More...
TG Therapeutics, Inc. (MHA) Announces FDA Clearance to Commence Clinical Trials of Its Novel, PI3K-Delta Specific Inhibitor, TGR-1202, Under Its Recently Filed U.S. Investigational New Drug (IND) Application 1/3/2013  More...
FDA Clears IND for First Clinical Trial Protocol Developed Using Crowdsourcing 12/18/2012  More...
Amarin Corporation PLC (AMRN) Announces Completion of Dosing in a Fixed-Dose Combination Study With Vascepa® and a Leading Statin 12/17/2012  More...
Invion Announces Successful Pre-Ind Meeting on INV103 (Cpn10) for the Treatment of Lupus 12/13/2012  More...
Results From Gentium S.p.A.'s Treatment IND for Defibrotide Presented at the American Society of Hematology Annual Meeting 12/13/2012  More...
Sunshine Biopharma, Inc. Completes Another IND-Enabling Study: Adva-27a is Found to be Effective Against Multidrug Resistant Uterine Cancer Cells 12/10/2012  More...
La Jolla Pharmaceutical Company (LJPC) Announces FDA Approval of IND 12/5/2012  More...
Sunshine Biopharma, Inc. Completes Six IND-Enabling Studies for Its Anticancer Compound, Adva-27a 12/4/2012  More...
Galapagos NV (GLPG.BR) Opens IND for GLPG0634 in the U.S. 12/3/2012  More...
Avaxia Biologics, Inc. Receives IND Clearance From FDA to Initiate Clinical Program to Evaluate AVX-470 as Therapy for Ulcerative Colitis 11/27/2012  More...
AtheroNova Inc. (AHRO.OB) Announces Milestone Filing of IND in Russian Federation 11/13/2012  More...
Hanmi Pharmaceutical, Co., Ltd and Kinex Pharmaceuticals Announced Korean FDA Allowance of the KX01 IND Application 11/7/2012  More...
TSRL, Inc. Reaches a Key Milestone With Pre-IND Meeting 10/26/2012  More...
TONIX Pharmaceuticals, Inc. Completes Pre-IND Meeting With FDA for Potential New Treatment for Post-Traumatic Stress Disorder 10/24/2012  More...
Avedro, Inc. Release: Keraflex® Keratoconus Treatment Study Begins in U.S. 10/12/2012  More...
Genesis Biopharma, Inc. Receives FDA Meeting Minutes From Contego™ Pre-IND Meeting 10/11/2012  More...
Sunshine Biopharma, Inc. Receives Scale-Up Manufacturing Protocol for Its Lead Anti-Cancer Compound, Adva-27a 10/9/2012  More...
Tesaro, Inc. Announces Clearance of Investigational New Drug Application for TSR-011 10/3/2012  More...
Investigational New Drug Application Cleared for Omeros Corporation (OMER)' Lead Compound in PDE10 Program 10/2/2012  More...
Synergy Pharmaceuticals Files IND for SP-333, a Developmental Drug for Gastrointestinal Diseases 9/12/2012  More...
Cold Genesys, Inc. Continuing Development of CG0070 Oncolytic Virus With GMCSF Expression 9/7/2012  More...
Omeros Corporation (OMER) Files Investigational New Drug Application for Lead Compound in PDE10 Program 9/6/2012  More...
Soligenix (SNGX.OB) Receives IND Clearance From FDA to Initiate Clinical Program to Evaluate SGX203 as Therapy for Pediatric Crohn's Disease 9/6/2012  More...
Invion Limited Release: Pre-Ind Meeting for Xtoll in Lupus Scheduled With FDA 9/5/2012  More...
Proacta Inc. Announces IND Allowance for PR610 8/29/2012  More...
Apexigen Announces the Filing of an IND by its Partner, 3SBio Inc. (SSRX) 8/16/2012  More...
Isconova's Adjuvant Matrix-M Approved by FDA for an IND Clinical Trial 8/15/2012  More...
Ferrer Submits IND for Arasertaconazole Nitrate, a Safe, Fast-Acting Topical Antifungal in Development for Vulvovaginal Candidiasis 8/7/2012  More...
Ampio Pharmaceuticals, Inc. (AMPE) Announces Successful Pre-IND Meeting With the Ophthalmology Division of the FDA on Optina™ for the Treatment of Diabetic Macular Edema 8/1/2012  More...
Camargo Pharmaceutical Services Fast Tracks 505(b)(2) Indian Products 7/24/2012  More...
pSivida Corp (PSDV) Receives FDA Clearance for Pivotal Trials for Injectable Sustained-Release Micro-Insert to Treat Uveitis 7/19/2012  More...
TherapeuticsMD, Inc. Announces Plans in Hormone Therapy That Concur With the Recent Joint Statement from NAMS, ASRM and The Endocrine Society 7/10/2012  More...
Capricor Announces FDA Approval to Initiate ALLSTAR Trial of Allogeneic Stem Cell Therapy in Patients Following Heart Attack 7/9/2012  More...
Ampio Pharmaceuticals, Inc. (AMPE) Reports Successful Type B Pre-IND Meeting with the FDA for Its Drug Zertane™ to Treat Premature Ejaculation (PE) 6/21/2012  More...
AVANIR Pharmaceuticals (AVNR) Announces FDA Acceptance Of IND For AVP-923 For The Treatment Of Agitation In Patients With Alzheimer's Disease 6/11/2012  More...
Arrowhead Research Corporation (ARWR) Advances ARC-520 into IND-Enabling Studies for the Treatment of Hepatitis B and Provides Guidance on Development Timeline 6/6/2012  More...
FivePrime Therapeutics, Inc. Announces That Human Genome Sciences Files U.S. IND for HGS1036/FP-1039 FGF Ligand Trap 6/4/2012  More...
RXi Pharmaceuticals (RXII) Receives FDA Clearance to Begin Clinical Trial With RXI-109 5/31/2012  More...
Soricimed Biopharma, Inc. Receives IND Clearance to Commence Phase I Trial of New Cancer Drug 5/30/2012  More...
Zogenix, Inc. Submits IND for Second DosePro(R) Candidate Relday(TM) 5/30/2012  More...
RetroSense Therapeutics Completes pre-IND Meeting for RST-001 5/24/2012  More...
Cellceutix (CTIX) Files Amended IND With FDA for Its Novel p53 5/21/2012  More...
Neuren Pharmaceuticals Limited Holds Pre-IND Meeting on Proposed Rett Syndrome Clinical Trials With FDA 5/17/2012  More...
Ambit Biosciences and Teva Pharmaceutical Industries Limited (TEVA) Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor 5/17/2012  More...
TG Therapeutics, Inc. (MHA) Announces Investigational New Drug (IND) for TGTX-1101, Receives Clearance by the FDA to Commence Clinical Trials in the U.S. 5/15/2012  More...
Ampio Pharmaceuticals, Inc. (AMPE) Reports Pre-IND Meeting With the FDA to Obtain Clinical Path Guidance for Ampion™ for the Treatment of Chronic Pain of Osteoarthritis of the Knee and Schedules May 16th Webcast to Update Shareholders 5/11/2012  More...
Immunomic Therapeutics Receives IND Authorization for Phase I Study of JRC-LAMP-Vax Vaccine to Treat Japanese Red Cedar (Sugi) Allergy 5/4/2012  More...
Lixte Biotechnology Announces Submission of an IND to the FDA for Approval of a Clinical Trial of LB-100, a First-in-Class, Anti-Cancer Compound 5/1/2012  More...
Cleveland Biolabs Inc. (CBLI) and Incuron Announce Russian Regulatory Allowance of IND for Phase 1B Trial of CBLC137 4/30/2012  More...
Tengion Inc. Announces IND Filing for Neo-Kidney Augment Expected During First Half of 2013 4/18/2012  More...
Medgenics, Inc. Files IND Application for EPODURE Biopump Phase IIb Anemia Study in Dialysis Patients 4/17/2012  More...
ImmunoGen, Inc. (IMGN) Announces the IND Is Now Active for Its Folate-Receptor Targeting Anticancer Compound, IMGN853 4/17/2012  More...
FDA Schedules a Date With Cellceutix (CTIX) on New Psoriasis Drug 4/16/2012  More...
Cerecor Inc. Announces Clearance of IND for FP01 4/11/2012  More...
Marshall Edwards, Inc. (MSHL) Receives FDA Approval of Investigational New Drug Application for Clinical Testing of Oncology Drug Candidate ME-344 4/10/2012  More...
Ampio Pharmaceuticals, Inc. (AMPE) Submits Pre-IND Package on Zertane to FDA 4/9/2012  More...
Frontage Laboratories Begins Early Phase Clinical Program for Hisun Pharma 4/4/2012  More...
Cannabis Science Inc. Continues Forward with FDA IND Process as Patients Report Successful Cancer Treatments 4/2/2012  More...
NanoViricides, Inc. (NNVC.PK) Announces Successful Pre-IND Meeting With the US FDA 4/2/2012  More...
Ablynx Receives Milestone Payment as Collaborator Receives IND Approval for a Nanobody in Oncology 4/2/2012  More...
Tengion Inc. Announces Significant Advances in Neo-Urinary Conduit(TM) and Neo-Kidney Augment(TM) Programs 3/27/2012  More...
FDA Accepts PaxVax, Inc.’s IND for Single-Dose Oral Cholera Vaccine 3/19/2012  More...
Cellceutix (CTIX) Files Pre-IND Documentation to FDA for New Psoriasis Drug 3/12/2012  More...
Cannabis Science Inc. Confirms Target Indication for FDA and Prepares for Pre-IND Meeting with the FDA with its Team of FDA Specialists 3/12/2012  More...
Viral Genetics Inc. (VRAL) Submits Pre-IND Document for Lyme Disease Drug Candidate to FDA 3/7/2012  More...
NanoViricides, Inc. (NNVC.PK) Announces US FDA has Confirmed Pre-IND Meeting Date 3/5/2012  More...
Tau Therapeutics, LLC IND Accepted by FDA for Novel Cancer Drug 2/28/2012  More...
S1 Pharmaceuticals, Inc. Announces IND Filing of SIP-104 (Lorexys) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) 2/21/2012  More...
Coronado Biosciences Announces IND Submission for CNDO-109 for the Treatment of Relapsed Acute Myeloid Leukemia 2/14/2012  More...
Neurelis Announces FDA Allowance of IND Application for NRL-1, a Novel Intranasal Diazepam Formulation 2/7/2012  More...
ZIOPHARM, Inc. Announces FDA Acceptance of IND for Oral Palifosfamide 2/6/2012  More...
OptiNose AS Files Investigational New Drug Application to use Sumatriptan Delivered with its Novel Drug Delivery Technology 2/3/2012  More...
NanoViricides, Inc. (NNVC.PK) Submits Pre-IND Briefing Document for its Anti-Influenza Drug, FluCide™, to the US FDA 1/31/2012  More...
Cancer Patient Success Prompts Cannabis Science Inc. to Begin FDA Investigational New Drug (IND) Application Process 1/25/2012  More...
FDA Grants Orphan Drug Designation to Ikaria Inc. For Use of Inhaled Nitric Oxide in Pulmonary Arterial Hypertension 1/24/2012  More...
Avila Therapeutics Announces FDA Allowance of Partner Clovis Oncology (CLVS)’s IND Application for CO-1686, an Oral EGFR Mutant-Selective Inhibitor, Triggers $4 Million Milestone Payment to Avila 1/20/2012  More...
Repros Therapeutics Inc. (RPRX)' IND for Proellex(R)-V Accepted By the FDA 1/5/2012  More...
FDA Approval to Commence Huntington's Disease Clinical Trial Using PRANA Biotechnology (PRAN)'s PBT2 1/4/2012  More...
Arrowhead Research Corporation (ARWR) Announces FDA Clearance to Initiate AdipotideTM Phase I Clinical Trial 1/4/2012  More...
BioMarin Pharmaceutical Inc. (BMRN) Announces IND for BMN-111 for Achondroplasia is Active 1/3/2012  More...
Phage Pharmaceuticals (Formerly Known as Phage Biotechnology Corp.) to File Investigational New Drug (IND) Application Using Its Lead Drug Candidate, FGF-1, for a First-in-Class Indication to Repair Tympanic Membrane Perforations 12/21/2011  More...
Oncothyreon Files Investigational New Drug Application for ONT-10 12/20/2011  More...
FDA Agrees With AtheroNova Inc. (AHRO.OB)'s Clinical Development Plan as Proposed 12/15/2011  More...
ContraFect Corporation Completes Successful Pre-IND Meeting With FDA 12/14/2011  More...
Results From Gentium S.p.A.'s Treatment IND for Defibrotide Presented at the American Society of Hematology Annual Meeting 12/13/2011  More...
NanoViricides, Inc. (NNVC.PK) Announces That It Has Submitted a Pre-IND Meeting Request to the US FDA For Its Anti-Influenza Clinical Drug Candidate, FluCide™ 12/5/2011  More...
Spectrum Pharmaceuticals, Inc. (SPPI) Files IND Application with U.S. FDA for SPI-014 12/5/2011  More...
AEterna Zentaris (AEZS): FDA Grants IND to Investigator at Baylor College of Medicine for Phase 2A Trial with AEZS-130 in Cancer Cachexia 11/28/2011  More...
Advaxis, Inc. Completes Pre-IND Meeting for ADXS-HER2 11/23/2011  More...
Apricus Biosciences (APRI) Announces That Its NexACT(R) Partner Exodos Life Sciences Has Completed Its pre-IND Meeting With the FDA 11/15/2011  More...
Vanton Research Laboratory's Infusion Delivery System for an Oncologic NCE Will Proceed with IND 11/15/2011  More...
Clinical Hold Removed for Helix Biopharma (CC:HBP)'s Topical Interferon Alpha-2b Phase II/III Efficacy Trial IND Application 11/11/2011  More...
Cellceutix Files Investigational New Drug Application (IND) With FDA, Clinical Trials Planned at Dana-Farber Cancer Institute/Harvard Cancer Center 11/7/2011  More...
Circadian Technologies Limited (CIR.AX) Receives FDA IND Approval to Begin Clinical Trials With VGX-100 for the Treatment of Cancer Patients With Solid Tumors 10/31/2011  More...
AtheroNova Inc. (AHRO.OB) Completes Successful Pre-IND Meeting with FDA on AHRO-001 10/26/2011  More...
AEterna Zentaris (AEZS): FDA Grants IND to Investigator at University of Miami School of Medicine for Phase 2 Trial with AEZS-108 in Triple-Negative Breast Cancer 10/25/2011  More...
AEterna Zentaris (AEZS): FDA Grants IND to Investigator at University of Miami School of Medicine for Phase 2 Trial with AEZS-108 in Triple-Negative Breast Cancer 10/25/2011  More...
Cleveland Biolabs Inc. (CBLI) Announces Opening of New IND for CBLB502 in Cancer Patients 10/19/2011  More...
Oxford BioMedica PLC (OXB.L) Announces US IND Approval for Novel Ocular Product in Usher Syndrome Type 1B 10/18/2011  More...
Helix Biopharma (CC:HBP) Files IND Clinical Hold Response With FDA for Its Planned Topical Interferon Alpha-2b Phase II/III Efficacy Trial 10/13/2011  More...